Haemophilia care in Europe: A survey of 19 countries

Haemophilia

Volumn 17, Issue 1, 2011, Pages 35-40

  O'mahony, B ^a   Noone, D ^a   Giangrande, P L F ^b   Prihodova, L ^c  

^a IRISH HAEMOPHILIA SOCIETY   (Ireland)

^b Oxford Haemophilia and Thrombosis Centre   (United Kingdom)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Organisation; Specialist care; Treatment

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE;

ARTICLE; CRYOPRECIPITATE; DRUG EFFICACY; DRUG SAFETY; EUROPE; HEALTH SURVEY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HOME CARE; HUMAN; IMMUNOLOGICAL TOLERANCE; MEDICAL SOCIETY; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; VON WILLEBRAND DISEASE;

DELIVERY OF HEALTH CARE; EUROPE; FACTOR VIII; HEALTH SERVICES ACCESSIBILITY; HEMOPHILIA A; HOME CARE SERVICES; HUMANS; QUESTIONNAIRES;

EID: 79951864947     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02362.x     Document Type: Article

References (7)

1. Colvin BT, Astermark J, Fischer K et al. European principles of haemophilia care. Haemophilia 2008; 14: 361-74.
2. The World Factbook, Central Intelligence Agency. Available at Accessed December 5, 2009.
3. O'Mahony B. Guide to National Tenders for the Purchase of Clotting factor Concentrates, WFH, 2006.
4. Blood safety in the European Community: an initiative for optimal use. European Commission 1999 (ISBN 3-00-005705-6).
5. Essential medicines, WHO Model list (revised March 2005). 14th edn. Available at
6. Evatt BL. Observation from Global Survey 2001: an emerging database for progress. Haemophilia 2002; 8: 153-56.
7. Stonebraker JS, Brooker M, Amand RE, Srivastava A. A study of reported factor VIII use around the world. Haemophilia 2010; 16: 33-46.